PPA
ATOS icon

Parametric Portfolio Associates’s Atossa Therapeutics ATOS Stock Holding History

Parametric Portfolio Associates’s Portfolio ATOS Stock Details ATOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5,884
Closed -$141K – 3680
2021
Q4 		$141K Buy
5,884
+4,820
+453% +$176K ﹤0.01% 3496
2021
Q3 		$52K Sell
1,064
-2,411
-69% -$140K ﹤0.01% 3572
2021
Q2 		$329K Buy
+3,475
New +$184K ﹤0.01% 3242

Other funds holding ATOS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Parametric Portfolio Associates's ATOS Position: Q1 2022 in Review

Parametric Portfolio Associates sold out of Atossa Therapeutics (ATOS) in Q1 2022, closing a stake of 5,884 shares — an estimated $141K sold.

Parametric Portfolio Associates first reported a position in ATOS in Q2 2021 and held it in 3 quarters. The position peaked at $329K in Q2 2021. 83 funds tracked by Wall St. Rank hold ATOS as of Q1 2022.

  • Parametric Portfolio Associates reported no remaining Atossa Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Parametric Portfolio Associates sold 5,884 Atossa Therapeutics shares in Q1 2022, an estimated $141K.
  • Parametric Portfolio Associates first reported a position in Atossa Therapeutics in Q2 2021 and held it in 3 quarters.
  • Parametric Portfolio Associates's Atossa Therapeutics position peaked at $329K in Q2 2021.
  • 83 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.